Skip to content

A clinical study on the therapeutic effect of layered reinforcing - reducing needling at pathological Zusanli (ST36) and Shangjuxu (ST37) for postoperative structural - deficiency gastroparesis

A clinical study on the therapeutic effect of layered reinforcing - reducing needling at pathological Zusanli (ST36) and Shangjuxu (ST37) for postoperative structural - deficiency gastroparesis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000381
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post surgical gastroparesis syndrome

Interventions

Non-acupuncture blank control group:Standardized Western medicine treatment
Single-needle acupuncture control group:Standardized Western medicine treatment + Single-needle acupuncture
Double-needle acupuncture test group:Standardized Western medicine treatment + Double-needle stratified reinforcing and reducing

Sponsors

The First Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Aged between 18 and 75 years old; Meeting the diagnostic criteria for postoperative gastroparesis syndrome; Without severe mental illness or contraindications to acupuncture; Having sufficient cognitive function and language ability to communicate and complete the learning questionnaire; Volunteering to participate in this randomized controlled study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: Patients diagnosed with mechanical obstruction or stenosis of the digestive tract; Patients under 18 years old or over 75 years old; Obvious disorders of water, electrolyte and acid - base balance. Patients with gastroparesis caused by diabetes or other diseases. Patients who have used other forms of non - drug interventions (such as physiotherapy, other traditional Chinese medicine treatments); Patients with severe infection or coagulation dysfunction; Patients unable to tolerate acupuncture; Pregnant women, lactating women or subjects planning to have children within two years; Severe heart, kidney and other organ dysfunctions, such as arrhythmia (requiring anti - arrhythmic drugs or pacemaker implantation), uncontrollable hypertension, a history of myocardial infarction within 6 months, QT interval prolongation exceeding 450 ms, congestive heart failure > NYHA class 2; Other serious diseases, such as alcoholism, drug abuse or mental and psychological diseases, which may affect informed consent or the patient's ability to cooperate;

Design outcomes

Primary

MeasureTime frame
Gastroparesis Cardinal Symptom Index;

Secondary

MeasureTime frame
Bowel sounds;Gastric juice volume;The time of anal exhaust;First defecation time;Number of days of nasogastric tube indwelling;Length of hospital stay;

Countries

China

Contacts

Public ContactZhanmou Liang

The First Affiliated Hospital, Sun Yat-sen University

1206706439@qq.com18813966010

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026